Showing results (1611-1620 of 2,184) with videos related to

Sort By:
Pageof 219
Clinical Lung Cancer|January 1, 2025
A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)Masayuki Takeda, Masahide Ota, Eiji Iwama, et al.
International Journal of Hematology|November 1, 2019
Genetic analysis of a compound heterozygous patient with congenital factor X deficiency and regular replacement therapy with a prothrombin complex concentrateTomoki Togashi, Satomi Nagaya, Masayuki Nagasawa, et al.
The International Journal of Cardiovascular Imaging|July 24, 2023
Multimodality coronary imaging to predict non-culprit territory unrecognized myocardial infarction in Non-ST-Elevation acute coronary syndromeMasahiro Hoshino, Tomoyo Sugiyama, Yoshihisa Kanaji, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 7, 2019
[Follicular lymphoma accompanied by paraneoplastic pemphigus and bronchiolitis obliterans: a case report]Ken Watanabe, Kota Yoshifuji, Tatsuya Saito, et al.
Internal Medicine (Tokyo, Japan)|November 16, 2020
A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast CancerTaizo Hirata, Shinji Ozaki, Masahiro Tabata, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 1, 2025
Chest pain patterns and coronary microvascular function in non-obstructive coronary artery diseaseKai Nogami, Yoshihisa Kanaji, Takumi Toya, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 27, 2005
Three-dimensional visualization of the coronary venous system using multidetector row computed tomographyHiroshi Tada, Kenji Kurosaki, Shigeto Naito, et al.
Biomedical Reports|May 19, 2018
Comparison of MRI and 123I-FP-CIT SPECT for the evaluation of MSA-P clinical severityMiki Nishimori, Yoriko Murata, Hitomi Iwasa, et al.
Thrombosis and Haemostasis|April 29, 2017
Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigensTakehisa Kitazawa, Keiko Esaki, Tatsuhiko Tachibana, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In VitroMariko Noguchi-Sasaki, Tetsuhiro Soeda, Atsunori Ueyama, et al.
Pageof 219